Literature DB >> 31904546

Modulation of the MAPKs pathways affects Aβ-induced cognitive deficits in Alzheimer's disease via activation of α7nAChR.

Ke-Wei Chang1, Hang-Fan Zong1, Mohammad Yasir Rizvi1, Kai-Ge Ma2, Wanying Zhai3, Meng Wang1, Wei-Na Yang4, Sheng-Feng Ji4, Yi-Hua Qian5.   

Abstract

Cognitive impairment in Alzheimer's disease (AD) is characterized by being deficient at learning and memory. Aβ1-42 oligomers have been shown to impair rodent cognitive function. We previously demonstrated that activation of α7nAChR, inhibition of p38 or JNK could alleviate Aβ-induced memory deficits in Y maze test. In this study, we investigated whether the effects of α7nAChR and MAPKs on Y maze test is reproducible with a hippocampus-dependent spatial memory test such as Morris water maze. We also assessed the possible co-existence of hippocampus-independent recognition memory dysfunction using a novel object recognition test and an alternative and stress free hippocampus-dependent recognition memory test such as the novel place recognition. Besides, previous research from our lab has shown that MAPKs pathways regulate Aβ internalization through mediating α7nAChR. In our study, whether MAPKs pathways exert their functions in cognition by modulating α7nAChR through regulating glutamate receptors and synaptic protein, remain little known. Our results showed that activation of α7nAChR restored spatial memory, novel place recognition memory, and short-term and long-term memory in novel object recognition. Inhibition of p38 restored spatial memory and short-term and long-term memory in novel object recognition. Inhibition of ERK restored short-term memory in novel object recognition and novel place recognition memory. Inhibition of JNK restored spatial memory, short-term memory in novel object recognition and novel place recognition memory. Beside this, the activation of α7nAChR, inhibition of p38 or JNK restored Aβ-induced levels of NMDAR1, NMDAR2A, NMDAR2B, GluR1, GluR2 and PSD95 in Aβ-injected mice without influencing synapsin 1. In addition, these treatments also recovered the expression of acetylcholinesterase (AChE). Finally, we found that the inhibition of p38 or JNK resulted in the upregulation of α7nAChR mRNA levels in the hippocampus. Our results indicated that inhibition of p38 or JNK MAPKs could alleviate Aβ-induced spatial memory deficits through regulating activation of α7nAChR via recovering memory-related proteins. Moreover, p38, ERK and JNK MAPKs exert different functions in spatial and recognition memory.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid-β; MAPKs pathways; α7nAChR

Year:  2020        PMID: 31904546     DOI: 10.1016/j.nlm.2019.107154

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  5 in total

1.  Impaired Learning and Memory Ability Induced by a Bilaterally Hippocampal Injection of Streptozotocin in Mice: Involved With the Adaptive Changes of Synaptic Plasticity.

Authors:  Cong-Cong Qi; Xing-Xing Chen; Xin-Ran Gao; Jing-Xian Xu; Sen Liu; Jin-Fang Ge
Journal:  Front Aging Neurosci       Date:  2021-03-01       Impact factor: 5.750

Review 2.  The Toxicity and Polymorphism of β-Amyloid Oligomers.

Authors:  Ya-Ru Huang; Rui-Tian Liu
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

3.  Detrimental effects of long-term elevated serum uric acid on cognitive function in rats.

Authors:  Tian Tian; Xi-Run Liu; Ting-Ting Li; Zhi-Chao Nie; Shuang-Jing Li; Yan Tang; Cong-Wei Gu; Wang-Dong Xu; Hong Jia
Journal:  Sci Rep       Date:  2021-03-24       Impact factor: 4.379

4.  Diversity and molecular network patterns of symptom phenotypes.

Authors:  Zixin Shu; Jingjing Wang; Hailong Sun; Ning Xu; Chenxia Lu; Runshun Zhang; Xiaodong Li; Baoyan Liu; Xuezhong Zhou
Journal:  NPJ Syst Biol Appl       Date:  2021-11-30

Review 5.  The Influence of Serum Uric Acid on the Brain and Cognitive Dysfunction.

Authors:  Natasa R Mijailovic; Katarina Vesic; Milica M Borovcanin
Journal:  Front Psychiatry       Date:  2022-04-22       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.